BIODRUGS

期刊基本信息

  • 期刊名称:BIODRUGS
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore)
  • 期刊ISSN:1173-8804
  • 期刊EISSN:1179-190X
  • 简称:BIODRUGS
  • 影响因子:6.9
  • 实时影响因子:截止2025年5月19日:6.855
  • 五年影响因子:6
  • JCI期刊引文指标:1.16
  • h-index:60
  • 2024-2025自引率:2.90%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://www.editorialmanager.com/bdra
  • 是否OA开放访问:No
  • 出版商:Springer International Publishing
  • 出版年份:1994

BIODRUGS

Science Citation Index Expanded (SCIE)Scopus (CiteScore)

期刊介绍

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

期刊语言要求

Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

投稿要求

  • 通讯方式:ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311
  • 涉及的研究方向:医学-免疫学
  • 出版国家或地区:NEW ZEALAND
  • 出版语言:English
  • 年文章数:55
  • PubMed Central (PMC)链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-8804%5BISSN%5D
  • 平均录用比例:较易

CITESCORE

CiteScoreSJRSNIPCiteScore排名
10.602.2901.621
学科分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q118 / 275
93%
大类:Medicine
小类:Pharmacology
Q131 / 321
90%
大类:Medicine
小类:Biotechnology
Q149 / 314
84%

WOS期刊JCR分区

WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:IMMUNOLOGYSCIEQ125/183
86.6%
学科:ONCOLOGYSCIEQ146/326
86%
学科:PHARMACOLOGY & PHARMACYSCIEQ124/352
93.3%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:IMMUNOLOGYSCIEQ135/183
81.15%
学科:ONCOLOGYSCIEQ165/326
80.21%
学科:PHARMACOLOGY & PHARMACYSCIEQ162/353
82.58%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区2区1区
IMMUNOLOGY
免疫学
3区2区2区
ONCOLOGY
肿瘤学
4区3区2区
PHARMACOLOGY & PHARMACY
药学
3区3区2区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 4区2区3区
PHARMACOLOGY & PHARMACY
药学
1区1区1区
IMMUNOLOGY
免疫学
4区3区2区
ONCOLOGY
肿瘤学
2区1区2区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友